Steve Nissen

Dr. Steve Nissen from Cleveland Clinic, a leading figure in lipoprotein(a) research, joins Dr. Greg Katz from NYU to delve into crucial insights about this underappreciated lipid layer. They discuss why Lp(a) is essential for evaluating cardiovascular risk and who should be tested. Listeners will learn about interpreting results, managing elevated levels, and the potential roles of aspirin and PCSK9 inhibitors. The episode highlights the evolving strategies in understanding and treating Lp(a), offering a fresh perspective on patient care.

CardioNerds talk with Dr. Steve Nissen about managing obesity in cardiovascular care. They discuss bariatric surgery, new medications, and the importance of addressing obesity. Dr. Nissen highlights the impact of obesity on cardiovascular health worldwide and the benefits of weight loss strategies.

Dr. Steven Nissen, the Chief Academic Officer at the Cleveland Clinic and a leading expert in cardiology, joins Dr. Thomas Nero to discuss the critical role of lipoprotein(a) in cardiovascular disease. They emphasize the necessity of routine testing for Lp(a), particularly for those with family histories of heart disease. The conversation includes challenges in lowering Lp(a) levels, the limitations of current treatments, and insights into ongoing clinical trials for drugs like pellicarsin. Real patient scenarios highlight aggressive strategies for managing elevated LDL post-myocardial infarction.